Who is sponsoring NCT04911985?

NCT04911985 is sponsored by University of Zurich.

What drugs are being tested in NCT04911985?

Interventions in NCT04911985: Measurement of the Cardiac Output/ Cardiac Index.

What condition does NCT04911985 study?

NCT04911985 studies Cardiogenic Shock.

Is NCT04911985 still recruiting?

NCT04911985 is currently completed. Last updated 8 June 2021.

Last reviewed 2021-06-08 · How we verify

NCT04911985

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Viability of Pulsioflex Monitoring in ICU

Completed Last updated 8 June 2021

What this trial tests

trial testing Measurement of the Cardiac Output/ Cardiac Index in Cardiogenic Shock in 42 participants. Completed in 30 August 2019.

Timeline

1 July 2015

Primary endpoint
1 February 2019

30 August 2019

Quick facts

Lead sponsor	University of Zurich
Status	Completed
Study type	OBSERVATIONAL
Enrollment	42
Start date	1 July 2015
Primary completion	1 February 2019
Estimated completion	30 August 2019
Sites	1 location across Switzerland

Drugs / interventions tested

Measurement of the Cardiac Output/ Cardiac Index

Conditions studied

Cardiogenic Shock — all drugs for Cardiogenic Shock →

Sponsor

University of Zurich

Who can join

16 and older, any sex, with Cardiogenic Shock. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Goal of the Study is to Study the precision of semi-invasive cardiac index monitoring by means of the ProAQT (PULSION Medical Systems SE) sensor, whereby the pulmonary artery catheter will serve as gold standard.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiogenic Shock

Currently open trials in the same condition.

NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07345559 — Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock · NA · recruiting
NCT07374289 — On Scene ECPR in Ostrava · NA · recruiting
NCT07402018 — Intra-aortic Balloon Counterpulsation (IABC) Compliance · recruiting
NCT07309029 — Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR · recruiting

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04911985 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 8 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04911985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing